Annie Neild
General Counsel bei FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Profil
Annie Neild is currently the Executive VP & Head-Global Regulatory Affairs at NewAmsterdam Pharma Co. NV.
Previously, she worked as the Head-Regulatory Affairs at Corvidia Therapeutics, Inc. in 2020.
Ms. Neild holds a doctorate degree from Yale University.
Aktive Positionen von Annie Neild
| Unternehmen | Position | Beginn |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | General Counsel | 01.03.2021 |
Ehemalige bekannte Positionen von Annie Neild
| Unternehmen | Position | Ende |
|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | General Counsel | 01.07.2020 |
Ausbildung von Annie Neild
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |